DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
15,120
+510 (3.49%)
Apr 1, 2025, 3:30 PM KST
DongKook Pharmaceutical Revenue
In the year 2024, DongKook Pharmaceutical had annual revenue of 812.17B KRW with 11.10% growth. DongKook Pharmaceutical had revenue of 210.93B in the quarter ending December 31, 2024, with 12.27% growth.
Revenue
812.17B
Revenue Growth
+11.10%
P/S Ratio
0.82
Revenue / Employee
718.10M
Employees
1,131
Market Cap
664.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 812.17B | 81.17B | 11.10% |
Dec 31, 2023 | 730.99B | 69.35B | 10.48% |
Dec 31, 2022 | 661.65B | 67.45B | 11.35% |
Dec 31, 2021 | 594.19B | 35.09B | 6.28% |
Dec 31, 2020 | 559.10B | 76.82B | 15.93% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |